LinkedIn recognises two in demand UK healthcare start-ups in its annual list
Utilised by an array of professionals in the corporate world, LinkedIn has become an essential platform for recruiters, job seekers and those who wish to connect to those in a similar field.
The platform giant has recently released its take on the top 25 most innovative start-ups based in the United Kingdom, based on four objectives – employment growth, engagement, job interest and attracting talent. From computing and banking, to network security, we take a closer look at the top two healthcare companies which made the cut.
As wait times to see a health professional continue to rise, technology is playing an increasingly vital part to tackle not only a growing global population, but increased demands on traditional health services, ongoing staff shortages and escalating healthcare costs.
In a bid to make healthcare accessible, affordable and high quality, Babylon Health has put the control back in a user’s hands, where its membership base has grown to more than 1.4mn, spanning Europe, Asia and Africa.
Through the use of a smartphone app, users can speak to a medical professional in mere hours, not weeks. Harnessing artificial intelligence, a chatbot works to triage clinical symptoms and undertakes a health status assessment to ascertain whether a GP appointment is needed, or whether a user is in urgent need of clinical support.
Launched in the UK, the company has partnered with Chinese giant Tencent to expand its international presence and provide services to Chinese citizens through popular social messaging platform, WeChat. Partnering with over 38,000 medical facilities in the country, the move will see both companies work to deliver personal health assessments, treatment advice and individual health records to those who utilise its services.
Additionally, Babylon’s partnership with Korean giant, Samsung, has enabled the company to provide live video doctor appointments at all times, as well as manage and order prescriptions through its service ‘Ask an Expert, powered by Babylon,’ available for Samsung users.
- UnitedHealth acquires pharmaceutical company Genoa Healthcare for $2.5bn
- Aiva Health receives investment from Google’s Assistant Investment Program
- Aetna is set to sell its drug plan business to WellCare Health Plans
Back in the UK, Babylon has worked alongside the country’s National Health Service (NHS), as well as private health company, Bupa in a bid to drive higher quality and lower healthcare costs.
Such is its success, the company is set to invest up to $100mn to hire 500 researchers, scientists, and engineers over the next year to develop the use of its AI technology to diversify its service portfolio, Business Insider has recently reported.
Similarly, to Babylon Health, Medopad works alongside NHS Trusts, but also supports private health providers by unlocking valuable health data through machine learning and AI technology.
Additionally, the company has built strong partnerships with global players, such as Pfizer and Boston Scientific, as well as technology giants, Apple and Tencent.
Striving to improve patient care by empowering its users and supporting medical professionals, the company provides remote patient monitoring applications, mobile technology and advanced data analytics to deliver a highly personalised, efficient care experience, with operations in Europe and Asia.
Following the company’s visit to China alongside UK Prime Minister, Theresa May, Medopad has also walked away with over £100mn in healthcare deals.
The company’s recent acquisition of US start up, Sherbit will further cater towards its global expansion.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”